Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: old drug, new hope

Thanh Trung Phan, Ganesh Nallur Shivu, Anirban Choudhury, Khalid Abozguia, Chris Davies, Ulasini Naidoo, Ibrar Ahmed, Zaheer Yousef, John Horowitz, Michael Frenneaux

Research output: Contribution to journalArticlepeer-review

47 Citations (Scopus)


The objective of this study is to report on our 5-year collective experience on the use of perhexiline in the UK, in patients with chronic heart failure (CHF) and/or refractory angina with respect to 'real-life' drug side effects and toxicity, therapeutic drug level monitoring, 5 year mortality outcomes and predictors of response to perhexiline therapy.
Original languageEnglish
Pages (from-to)881-886
Number of pages6
JournalEuropean Journal of Heart Failure
Issue number9
Publication statusPublished - Sep 2009


  • Chronic heart failure
  • Refractory angina
  • Perhexiline
  • Mortality and drug monitoring

Cite this